Philips Medical Systems Netherlands B.V. recalled 1,117 X-ray imaging systems on September 3, 2025. The recall affects product codes 722010, 722026, and 722003 due to potential internal component deterioration. This issue may render motorized movements inoperable, posing a risk to patient care.
Systems may not perform as intended due to the deterioration of certain internal components (the CMOS battery, hard disk drive, and/or power supply unit). If this deterioration occurs, motorized movements of the system will become unavailable. Manual movements of the stand (longitudinal, transversal and rotational for ceiling mounted systems and rotational for floor mounted systems) and table longitudinal movements remain available. Imaging (X-ray) functionality remains available.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. or your healthcare provider for instructions. Notification method: Letter
The recall involves Philips X-ray imaging systems with product codes 722010, 722026, and 722003. These systems were distributed worldwide, including 252 units in the U.S. and 865 units internationally. The devices were distributed across multiple countries.
The systems may not perform as intended due to the deterioration of internal components such as the CMOS battery, hard disk drive, and power supply unit. If these components fail, motorized movements will become unavailable, potentially affecting patient imaging and care.
The recall does not specify any reported injuries or deaths associated with this issue. However, the high hazard level indicates a risk that could compromise patient safety.
Patients and healthcare providers should stop using the device immediately. Contact Philips Medical Systems or your healthcare provider for further instructions and follow the recall instructions provided.
For more information, contact Philips Medical Systems at their official website. The recall notification method is via letter.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.